To amend the Controlled Substances Act to place synthetic drugs in Schedule I.
What it does: Adds Subtitle D--Synthetic Drugs SECTION 1141. SHORT TITLE at the end of title XIWhat it changes
1 change to S. 3187 · shown in the bill's text
Adds Subtitle D--Synthetic Drugs SECTION 1141. SHORT TITLE at the end of title XI
Adds a sectionIn S. 3187 · Placed on Calendar Senate
"(b) Financial Interest.--In this section, the term 'financial interest' means a financial interest under section 208(a) of title 18, United States Code.".
Inserted: Subtitle D--Synthetic Drugs SECTION 1141. SHORT TITLE.
Inserted: This subtitle may be cited as the "Synthetic Drug Abuse Prevention Act of 2012".
Inserted: SEC. 1142. ADDITION OF SYNTHETIC DRUGS TO SCHEDULE I OF THE CONTROLLED SUBSTANCES ACT.
Inserted: (a) Cannabimimetic Agents.--Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended by adding at the end the following:
Inserted: "(d)(1) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of cannabimimetic agents, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.
Inserted: "(2) In paragraph (1):
Inserted: "(A) The term 'cannabimimetic agents' means any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist as demonstrated by binding studies and functional assays within any of the following structural classes:
Inserted: "(i) 2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.
Inserted: "(ii) 3-(1-naphthoyl)indole or 3-(1-naphthylmethane)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.
Inserted: "(iii) 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent.
Inserted: "(iv) 1-(1-naphthylmethylene)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent.
Inserted: "(v) 3-phenylacetylindole or 3-benzoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent.
Show 32 more inserted paragraphsShow less
Inserted: "(B) Such term includes--
Inserted: "(i) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP 47,497);
Inserted: "(ii) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP 47,497 C8-homolog);
Inserted: "(iii) 1-pentyl-3-(1-naphthoyl)indole (JWH 018 and AM678);
Inserted: "(iv) 1-butyl-3-(1-naphthoyl)indole (JWH 073);
Inserted: "(v) 1-hexyl-3-(1-naphthoyl)indole (JWH 019);
Inserted: "(vi) 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH 200);
Inserted: "(vii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH 250);
Inserted: "(viii) 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH 081);
Inserted: "(ix) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH 122);
Inserted: "(x) 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH 398);
Inserted: "(xi) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);
Inserted: "(xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);
Inserted: "(xiii) 1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR 19 and RCS 4);
Inserted: "(xiv) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR 18 and RCS 8); and
Inserted: "(xv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH 203).".
Inserted: (b) Other Drugs.--Schedule I of section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended in subsection (c) by adding at the end the following:
Inserted: "(18) 4-methylmethcathinone (Mephedrone).
Inserted: "(19) 3,4-methylenedioxypyrovalerone (MDPV).
Inserted: "(20) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C E).
Inserted: "(21) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C D).
Inserted: "(22) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C C).
Inserted: "(23) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C I).
Inserted: "(24) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C T 2).
Inserted: "(25) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C T 4).
Inserted: "(26) 2-(2,5-Dimethoxyphenyl)ethanamine (2C H).
Inserted: "(27) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C N).
Inserted: "(28) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C P).".
Inserted: SEC. 1143. TEMPORARY SCHEDULING TO AVOID IMMINENT HAZARDS TO PUBLIC SAFETY EXPANSION.
Inserted: Section 201(h)(2) of the Controlled Substances Act (21 U.S.C. 811(h)(2)) is amended--
Inserted: (1) by striking "one year" and inserting "2 years"; and
Inserted: (2) by striking "six months" and inserting "1 year".
Original wording
At the end of title XI, insert the following:
Read automatically from the Congressional Record. Check the original before relying on it.
As printed
SA 2146. Mr. PORTMAN submitted an amendment intended to be proposed by him to the bill S. 3187, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes; which was ordered to lie on the table; as follows:
At the end of title XI, insert the following:
Subtitle D--Synthetic Drugs SECTION 1141. SHORT TITLE.
This subtitle may be cited as the “Synthetic Drug Abuse Prevention Act of 2012”.
SEC. 1142. ADDITION OF SYNTHETIC DRUGS TO SCHEDULE I OF THE CONTROLLED SUBSTANCES ACT.
(a) Cannabimimetic Agents.--Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended by adding at the end the following:
“(d)(1) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of cannabimimetic agents, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.
“(2) In paragraph (1):
“(A) The term ‘cannabimimetic agents' means any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist as demonstrated by binding studies and functional assays within any of the following structural classes:
“(i) 2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.
“(ii) 3-(1-naphthoyl)indole or 3-(1-naphthylmethane)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.
“(iii) 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent.
“(iv) 1-(1-naphthylmethylene)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent.
“(v) 3-phenylacetylindole or 3-benzoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent.
“(B) Such term includes--
“(i) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP 47,497);
“(ii) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP 47,497 C8-homolog);
“(iii) 1-pentyl-3-(1-naphthoyl)indole (JWH 018 and AM678);
“(iv) 1-butyl-3-(1-naphthoyl)indole (JWH 073);
“(v) 1-hexyl-3-(1-naphthoyl)indole (JWH 019);
“(vi) 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH 200);
“(vii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH 250);
“(viii) 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH 081);
“(ix) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH 122);
“(x) 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH 398);
“(xi) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);
“(xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);
“(xiii) 1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR 19 and RCS 4);
“(xiv) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR 18 and RCS 8); and
“(xv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH 203).”.
(b) Other Drugs.--Schedule I of section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended in subsection (c) by adding at the end the following:
“(18) 4-methylmethcathinone (Mephedrone).
“(19) 3,4-methylenedioxypyrovalerone (MDPV).
“(20) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C E).
“(21) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C D).
“(22) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C C).
“(23) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C I).
“(24) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C T 2).
“(25) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C T 4).
“(26) 2-(2,5-Dimethoxyphenyl)ethanamine (2C H).
“(27) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C N).
“(28) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C P).”.
SEC. 1143. TEMPORARY SCHEDULING TO AVOID IMMINENT HAZARDS TO PUBLIC SAFETY EXPANSION.
Section 201(h)(2) of the Controlled Substances Act (21 U.S.C. 811(h)(2)) is amended--
(1) by striking “one year” and inserting “2 years”; and
(2) by striking “six months” and inserting “1 year”.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Senate amendment proposed (on the floor): Amendment SA 2146 proposed by Senator Harkin for Senator Portman.(consideration: CR S3545-3547, S3548-3550, S3555-3557)
May 24, 2012
View full timeline
Senate amendment proposed (on the floor): Amendment SA 2146 proposed by Senator Harkin for Senator Portman.(consideration: CR S3545-3547, S3548-3550, S3555-3557)
May 24, 2012
Senate amendment agreed to: Amendment SA 2146 as modified agreed to in Senate by Voice Vote.(text as modified: CR S3546)
May 24, 2012
Amendment SA 2146 proposed by Senator Harkin for Senator Portman. (consideration: CR S3545-3547, S3548-3550, S3555-3557) To amend the Controlled Substances Act to place synthetic drugs in Schedule I.
May 24, 2012
Amendment SA 2146 as modified agreed to in Senate by Voice Vote. (text as modified: CR S3546)
May 24, 2012
Senate amendment submitted
May 22, 2012